Surgery Partners’ (SGRY) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a research note issued to investors on Tuesday, MarketBeat.com reports. Cantor Fitzgerald currently has a $18.00 price objective on the stock.

A number of other research firms have also commented on SGRY. Jefferies Financial Group reiterated a “buy” rating and issued a $17.00 price target on shares of Surgery Partners in a research report on Wednesday, May 6th. Zacks Research upgraded Surgery Partners from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a research note on Tuesday, May 26th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Surgery Partners presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.45.

Surgery Partners Trading Down 0.8%

Shares of NASDAQ SGRY opened at $15.19 on Tuesday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.69 and a current ratio of 1.86. Surgery Partners has a 52-week low of $11.41 and a 52-week high of $24.10. The firm has a 50 day moving average price of $15.58 and a two-hundred day moving average price of $14.42. The stock has a market cap of $1.99 billion, a P/E ratio of -21.70, a price-to-earnings-growth ratio of 4.16 and a beta of 1.91.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.04. The company had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.87%. Surgery Partners’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.17 earnings per share. As a group, equities analysts forecast that Surgery Partners will post 0.25 EPS for the current year.

Institutional Trading of Surgery Partners

A number of large investors have recently bought and sold shares of SGRY. BlackRock Inc. bought a new position in shares of Surgery Partners in the 2nd quarter worth about $104,857,000. Pentwater Capital Management LP grew its stake in Surgery Partners by 66.9% during the third quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after purchasing an additional 4,681,000 shares during the period. UBS Group AG grew its stake in Surgery Partners by 111.4% during the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after purchasing an additional 4,113,052 shares during the period. Goldman Sachs Group Inc. increased its holdings in Surgery Partners by 528.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,959,686 shares of the company’s stock worth $30,277,000 after purchasing an additional 1,647,714 shares in the last quarter. Finally, Glenview Capital Management LLC bought a new stake in Surgery Partners in the second quarter worth approximately $33,995,000.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.